Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-23-101641

Chief Scientific Officer acquired 521 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Yocca Frank · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-14 Exercise or conversion : show line 1 in the form +521 10,538 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-14 Exercise or conversion : show line 2 in the form Restricted Stock Units −521 5,211 D
Loading xslF345X05/tm2326350-3_4seq1.xml…